Texas · Nonprofit
THE KIDNEY CANCER ASSOCIATION
THE KIDNEY CANCER ASSOCIATION (Texas) receives grants from 50 organizations whose IRS filings report $1,125,478 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($441,300). 20 of them have funded it in more than one year, and 71% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $4.9M
- Funders on record
- 50
- Grants received
- $1.1M
- Net assets
- $25M
What The Kidney Cancer Association does
Mission
The Kidney Cancer Association is a global community dedicated to serving and empowering patients, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer.
As stated on its FY2024 Form 990.
Programs
Education - The Kidney Cancer Association provides opportunities for physicians, researchers, academics, and industry professionals from across the globe to come together and exchange ideas that will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure. The primary opportunities are during the two annual symposia, ikcs north america and ikcs europe, held both in person. Ikcs meetings promote learning, networking, and unparalleled opportunities for mentorship and collaboration.
$2,237,246 spent45% of program spendingPatient support and advocacy - The Kidney Cancer Association seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer. The kca provides patient resources for each stage of the kidney cancer journey including our just diagnosed toolkit, patient navigator program, virtual patient symposium, kca connect, patient assistance fund, and educational resources including information on treatments, drugs, clinical trials, and caregiving to name a few.
$1,497,880 spentof which $38,064 as grants$281,639 earned by the program30% of program spendingResearch - The Kidney Cancer Association is committed to supporting healthcare professionals, fostering professional collaboration, and funding research that advances our understanding of kidney cancer. The organization awarded grants to physicians and scientists engaged in research targeting early detection and innovative treatments for kidney cancer.
$1,210,399 spentof which $420,261 as grants24% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $4,945,525.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $30M to $23M (−22%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 3%. Grants only. Government contracts and fees sit inside program revenue.
70% of THE KIDNEY CANCER ASSOCIATION’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Gretchen E Vaughan
President & CEO
Board chair
Bradley Leibovich
Board chair
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 6 funders to 18 funders, grant income rose $125k → $144k.
15 of 50 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 71% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of THE KIDNEY CANCER ASSOCIATION’s funders (the co-funder graph). Top 30 of 50 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
THE KIDNEY CANCER ASSOCIATION has a broad base — no single funder exceeds 39% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
74% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund THE KIDNEY CANCER ASSOCIATION.
Largest funder’s share by year: 2017 80% · 2018 50% · 2019 31% · 2020 35% · 2021 29% · 2022 66% · 2023 26% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
43% of THE KIDNEY CANCER ASSOCIATION's funders are still giving 3 years after their first grant; 40% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
71% of THE KIDNEY CANCER ASSOCIATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $330k that is directly attributable, 97% of it comes from funders outside Texas, across 18 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $795k arriving through sponsors registered in 12 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
THE KIDNEY CANCER ASSOCIATION is better cushioned than half of the 8,126 health nonprofits its size.
this organization peer median middle 50% of peers· 8,126 health nonprofits $1M–$10M, FY2024
Organizations like THE KIDNEY CANCER ASSOCIATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Texas
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
73% of spending goes to programs.
Governance
Public support
57%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for THE KIDNEY CANCER ASSOCIATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds THE KIDNEY CANCER ASSOCIATION?
- THE KIDNEY CANCER ASSOCIATION (Texas) receives grants from 50 organizations whose IRS filings report $1,125,478 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($441,300). 20 of them have funded it in more than one year, and 71% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does THE KIDNEY CANCER ASSOCIATION have?
- IRS filings report 50 organizations giving $1,125,478 in grants to THE KIDNEY CANCER ASSOCIATION, 20 of which have funded it in more than one year.
- Who is the largest funder of THE KIDNEY CANCER ASSOCIATION?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $441,300 in grants. The full list of funders is on this page.
- How can an organization like THE KIDNEY CANCER ASSOCIATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Texas. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 50 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing